Generic Name: Natalizumab
Brand Name: Tysabri
Manufacturer: Biogen Idec Canada Inc.
Therapeutic Area: Multiple Sclerosis, relapsing-remitting
Indications: Multiple Sclerosis, relapsing-remitting
Submission Type: Initial
Project Status: Complete
Date Recommendation Issued: April 26, 2007
Recommendation Type: Do not list